Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
voda schreef op 18 februari 2022 17:00 :
Amerikanen treffen Alibaba en Prosus
De Chinese e-commercereus Alibaba BABA -4,75% opent op Wall Street met een verlies van bijna 5 procent. Het platform AliExpress van Alibaba is opgenomen op een Amerikaanse lijst van merken die het auteursrecht en handelsmerken schenden. Op die lijst werd ook het sociaal medium WeChat van Tencent toegevoegd. Grootaandeelhouder Prosus
PRX -2,94% van Tencent neemt in Amsterdam een duik van bijna 3 procent. ‘Zowel AliExpress als WeChat faciliteren in belangrijke mate namaak’, klinkt het bij de Amerikanen. De VS stellen deze lijst jaarlijks bij.
www.tijd.be/markten-live/live-blog/oe... Hebonlangs lichtjes voor de fiets gekocht, geen bekend merk maar werken wel zeer goed en een pak goedkoper!
Ter infoAlibaba: Growing Pains Alibaba's (BABA) shares are down 50% over the last year but their bottom may not be in yet. Latest data reveals that institutional investors sold roughly 108 million of the company's shares during Q4 CY21 on a net basis. This development suggests that this class of investors doesn't perceive the stock to be undervalued just yet and, perhaps, also believes the stock has ample potential to fall even further in the foreseeable future. This should come across as a concerning sign for Alibaba's existing shareholders and dissuade those who are looking to initiate contrarian long positions in the name. The Institutional Exodus Let me start by saying that institutional investors aren't always right. However, they do have several tools at their disposal - such as access to company managements, resources to conduct legal analysis and perform scuttlebutt research, supply chain connections etc. - that gives them an edge over retail investors. So, tracking their trading activity can sometimes, if not always, can provide us with leading insights over where a stock might head next. With that said, institutional investors collectively sold approximately 108 million shares during the last 13F filings cycle. To put the magnitude of this selloff in perspective, the e-commerce giant has 2.7 billion shares outstanding which means these institutions collectively dumped about 4% of Alibaba's entire share total in the last quarter. Alibaba Business Quant Note that the number of institutions that sold Alibaba's shares during the quarter, significantly outnumbered those that bought into the stock. For the record, the 13F filings cycle under discussion spanned from October through December and the data was fully disseminated only this Tuesday. This means the data is still fresh and relevant for our discussion here. One might argue that this selloff isn't necessarily an alarming development as it might just be a one-time event. But fact of the matter is that institutions have been selling Alibaba's shares continuously for the last three quarters. When I started warning investors about the institutional selloff back in August 2021, these entities were holding approximately 26% of Alibaba's total shares outstanding. This figure has reduced to 17.7% since then and there's ample room for the selloff to still continue in the next couple of quarters. Next, I wanted to see if Alibaba's top 45 investors traded any differently. After all, if these top investors were net buyers in Alibaba, while a broad swath of other institutions were selling, then the contrarian long positions could've projected a bullish picture. But that apparently wasn't the case here. Per our database at Business Quant, 29 out of Alibaba's 45 largest investors were net sellers during Q4 CY21. This indicates that Alibaba's largest investors also lost confidence in the company's prospects and trimmed their positions during the quarter Changes in ownership for Alibaba Business Quant With that said, I wanted to see if institutional investors were bearish on the entire industry or if they were skeptical (or bearish) specifically on Alibaba. So, I pulled the institutional ownership data for 42 other internet retail stocks listed on US bourses. As it turns out, these institutions grew bullish on 30 other stocks in our study group but were relatively bearish on Alibaba. Change in institutional ownership during Q4, for internet retail stocks Business Quant This, again, projects a disconcerting picture for Alibaba's shareholders and begs the question - why are these institutions growing bearish on Alibaba in spite of its plummeting stock price? Reasons for Caution A major risk factor surrounding Alibaba's US-listed shares, are regulatory in nature. The SEC approved a framework in December, an it became effective last month, which requires foreign companies to open up to audit inspections or risk getting delisted. Maybe Alibaba complies with US regulators, opens to audit inspections and its books turn out to be in order. Or maybe, Alibaba opens up its books and US regulators find discrepancies in its numbers (remember Luckin Coffee accounting scandal?). Whether that happens, to what extent the fraud happens and what happens after that, is pure speculation and is anyone's best guess. Another possibility is Alibaba does not comply with US regulators and gets delisted from US bourses. The point that I'm trying to make here is that this risk factor didn't exist till a few quarters ago. Its emergence has significantly changed the risk profile involved with investing in Alibaba's US-listed shares, and institutional shareholders might just be adjusting their positions in the name accordingly. It's important to understand that institutional investors are entities that pool money to buy securities. They could range from mutual funds, hedge funds, pension funds, investment banks, ETFs, insurance companies or involve other organizational structures. Since these entities have different risk profiles, mandates, investing parameters and time horizons, all of them won't necessarily be bullish on Alibaba. For instance, pension funds have the paramount goal of beating inflation while preserving capital. Risk averse institutional investors such as these may be looking at safer investment opportunities elsewhere, rather than initiating contrarian long positions, or staying long, on Alibaba where the capital itself could be at risk. Besides, Chinese regulators imposed a $2.8 billion antitrust fine on Alibaba last year. Now, it can't strongarm its merchants anymore, and restrict them from listing their products on rival e-commerce platforms. This means that rival e-commerce platforms could gain at Alibaba's expense. The latter could increase its marketing spend but that won't guarantee any results. So, I expect Alibaba's margin profile to deteriorate and its growth momentum to decelerate in the coming quarters. But overall, this operational setback is another reason for institutional investors to rethink their investment thesis and trim their positions in Alibaba to better fit their risk appetite. Investors Takeaway There's no denying that Alibaba's shares are attractively valued at current levels, at least in terms of price-to-sales multiples. On the other hand, other rapidly growing internet retail stocks are trading at significantly higher valuation multiples. This relative undervaluation makes Alibaba seem like a lucrative contrarian buy opportunity. Alibaba Business Quant At the same time, let's also remember that institutional investors have been selling Alibaba's shares for several months now. If the stock truly offered risk-free explosive returns at its current levels, this class of sophisticated investors would've been actively buying Alibaba's shares in droves. But that clearly did not happen. There are serious risks involved with investing in Alibaba and that's why its shares are depressed. So, risk-averse investors may want to avoid the stock for the time being at least. On the other hand, contrarian investors with a higher risk appetite and a tolerance for significant portfolio drawdowns, may want to take advantage of the company's distressed stock price and accumulate it on dips for the long-term. Good Luck!
Growing pains inderdaad. Wat een ellende weer in Hong Kong. Maar wij blijven erin geloven, ook al stappen de grote jongens uit. Was dat bij shell ook niet het geval voor het grote herstel begon ? ;-)
Welk uur krijgen wij de resultaten te zien?
Rider schreef op 19 februari 2022 12:22 :
[...]
Hebonlangs lichtjes voor de fiets gekocht, geen bekend merk maar werken wel zeer goed en een pak goedkoper!
Ik hoop dat je lichtjes het nog goed doen. Het wordt nl erg donker komende tijd.
Dit kan er ook nog wel bij.Alibaba reports smallest rise in quarterly revenue, misses expectations Feb 24 (Reuters) - China's Alibaba Group Holding Ltd <9988.HK> on Thursday reported its slowest-ever increase in quarterly revenue since going public in 2014, as tepid growth in its core e-commerce business and intensifying competition ate into sales. The slowing Chinese economy has taken a toll on the e-commerce company, as consumers cut back discretionary spending. During its annual Singles' Day promotional event last November, the company recorded gross merchandise value growth of 8.5%, a record low. Alibaba is also facing intensifying pressure from rivals like TikTok-owned ByteDance and Kuaishou, who have capitalized on the booming trend of livestreaming e-commerce. In its fiscal third quarter, Alibaba re-organized its financial reporting of certain business segments to highlight new areas of growth. International commerce reached 16.45 billion yuan, up 18%. Local consumer services, which includes the company's food delivery apps, generated 12.14 billion yuan, up 27% from a year ago. Ant Group, Alibaba's fintech affiliate, posted a profit of about 17.6 billion yuan for the quarter ended September, according to Alibaba's filings, compared with 19.7 billion yuan in the previous quarter and 15 billion yuan a year ago. The group has been subjected to a sweeping restructuring by China, which derailed its $37 billion initial public offering in late 2020. Alibaba's shares were down about 3% in New York before the opening bell. They fell about 5% before the results were announced, tracking losses in global shares after Russia launched an all-out invasion of Ukraine. Net income attributable to shareholders slumped to 20.43 billion yuan in the third quarter from 79.43 billion yuan a year earlier.
Gemengde resultaten Alibaba Omzet viel tegen. (ABM FN-Dow Jones) Alibaba heeft in het derde kwartaal van zijn lopende boekjaar gemengde resultaten geboekt. Dit bleek donderdag uit de kwartaalcijfers van het Chinese e-commercebedrijf. De nettowinst kwam uit op 20,4 miljard Chinese yuan, of 3,2 miljard dollar, en 7,51 yuan per American depositary share. Dat was een jaar eerder nog 79,4 miljard en 28,85 yuan per ADS. De aangepaste winst van 16,87 yuan per ADS was wel beter dan de 15,93 yuan waar de markt op rekende. De omzet steeg van 221,1 tot 242,6 miljard yuan, waar analisten geraadpleegd door FactSet rekenden op 246,3 miljard yuan. Alibaba had eind december 1,28 miljard jaarlijks actieve klanten, waarvan het leeuwendeel in China. Dit is een stijging van 43 miljoen gebruikers. Het aandeel Alibaba noteert donderdag op Wall Street 3,5 procent lager. Door: ABM Financial News.info@abmfn.nl Redactie: +31(0)20 26 28 999
2.65 usd per share, toch niet slecht denk ik
Klopt, verwacht was $2.52. De omzetgroei vertraagt en dat is natuurlijk wel een dingetje bij een groeiaandeel. Aan de andere kant zit er al zoveel pijn in de koers dat die niet veel lager meer zal gaan. Maar dat dachten we een half jaar geleden ook.Alibaba’s revenue climbed 10% year over year, compared to 29% annual sales growth notched in the previous quarter. This is the slowest-ever revenue growth since Alibaba went public almost a decade ago and confirms that the tech giant faced a marked slowdown in growth at the end of 2021. It’s the worst part of Thursday’s release. In May, Alibaba projected more than $146 billion in sales for the year ending March 2022, which would have represented nearly 30% year-over-year growth. It cut that figure starkly in November, projecting revenue to grow 20% to 23%. Thursday’s update brought no new guidance, even though revenue dropped significantly. www.barrons.com/articles/alibaba-stoc...
Dividend Collector schreef op 25 februari 2022 10:39 :
Klopt, verwacht was $2.52. De omzetgroei vertraagt en dat is natuurlijk wel een dingetje bij een groeiaandeel. Aan de andere kant zit er al zoveel pijn in de koers dat die niet veel lager meer zal gaan. Maar dat dachten we een half jaar geleden ook.
Alibaba’s revenue climbed 10% year over year, compared to 29% annual sales growth notched in the previous quarter. This is the slowest-ever revenue growth since Alibaba went public almost a decade ago and confirms that the tech giant faced a marked slowdown in growth at the end of 2021. It’s the worst part of Thursday’s release. In May, Alibaba projected more than $146 billion in sales for the year ending March 2022, which would have represented nearly 30% year-over-year growth. It cut that figure starkly in November, projecting revenue to grow 20% to 23%.
Thursday’s update brought no new guidance, even though revenue dropped significantly. www.barrons.com/articles/alibaba-stoc... Omzet zal mss niet zoveel meer groeien maar als ze hun cashflow gebruiken om aandelen terug te kopen gaat de winst per aandeel omhoog en is goed voor de aandeelhouders.
Klopt, maar is dat een gezond en duurzaam verdienmodel?
Dividend Collector schreef op 25 februari 2022 17:23 :
Klopt, maar is dat een gezond en duurzaam verdienmodel?
Hun e-commerce is iets dat niet meer zal weggaan, mensen kopen meer en meer online ook Chinezen.. En als hun cloudservice nog wat kan groeien dan zie ik niet in waarom ze hun huidige omzet niet kunnen blijven aanhouden.
Lijkt erop dat de bodem gezet is? Toch moet ik mijzelf 4x per dag vetellen dat ik genoeg heb en niet bij moet kopen.. Lastig op deze koers.
Now what Alibaba? Koers weer in vrije val.
Zit op mijn handen en kijk toe. Heeft het iets met JD te maken?
Iemand enig idee wat er aan de hand is met $BABA? Koers op laagste niveau sinds Jan 2016 nu... Terwijl cijfers best prima zijn, en al die goedkope producten welkom in tijden van hoge inflatie? Enige logische verklaring die ik kan bedenken, dat er 1 hele grote aandeelhouder lang geleden alles voor een prikke gekocht heeft, en probeert maximaal te profiteren voordat de economie instort... Zag laatst wel een video met Charlie Munger die 'toekomst zag' in alibaba. Misschien moet ik dat interpreten als: ik heb veel aandelen die ik wil dumpen, ik zoek kopers?
Hoe zou het Rider vergaan? Hij zit volgens mij voor 80% in Baba, wat we maanden geleden al niet verstandig vonden.
Toch weer gezwicht om bij te kopen. Procentueel gezien wel veel te zwaar in Chineese aandelen en EFT's Het is iig nog niet mijn beursjaar.
Dividend Collector schreef op 10 maart 2022 18:50 :
Hoe zou het Rider vergaan? Hij zit volgens mij voor 80% in Baba, wat we maanden geleden al niet verstandig vonden.
Goed ik ben op reis momenteel en zit nog steeds in Baba, heb zelf nog een order die uitgevoerd is geweest. Verstandig is het misschien niet we zullen het zien binnen tien jaar.
www.bloomberg.com/news/articles/2022-... China Tech Selloff Deepens as U.S. Delisting Fears Alarm TradersHang Seng Tech Index falls as much as 8.9% before paring loss Delisting worries not new but add to weak sentiment: analysts “The selloff due to renewed concerns about ADR delisting is not logical as there is nothing new in the process that was not previously announced,” said Vey-Sern Ling, a senior analyst at Union Bancaire Privee. “Sentiment in the space is very weak, but the indiscriminate selling could prove to be good opportunity for longer-term investors.”
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
874,79
+0,96%
EUR/USD
1,0711
+0,08%
FTSE 100
8.044,81
+0,26%
Germany40^
18.161,70
+0,13%
Gold spot
2.321,67
-0,02%
NY-Nasdaq Composite
15.696,64
+1,59%
Stijgers
Dalers